Kobo Products Inc.

Kobo, United States

Kobo Products Inc.

Kobo, United States

Time filter

Source Type

Global Novel Drug Delivery Systems for Cancer Therapy Market by Technologies, Trends and Forecast to 2021, New Report by iHealthcareAnalyst, Inc. Novel Drug Delivery Systems for Cancer Therapy Market by Technology Types - Embolization Particles, Drug Eluting Beads, PVA Particles, Microspheres, Gelatin-Based, Selective Internal Radiation Therapy (SIRT), Therasphere, SIR-Spheres, Holmium-Based Microspheres, Liquid Embolics, Onyx (LES and HD-500), TRUFILL nBCA LES, and Nanoparticles and Forecast 2017-2021 Maryland Heights, MO, May 09, 2017 --( Browse Novel Drug Delivery Systems for Cancer Therapy Market by Technology Types - Embolization Particles, Drug Eluting Beads, PVA Particles, Microspheres, Gelatin-Based, Selective Internal Radiation Therapy (SIRT), Therasphere, SIR-Spheres, Holmium-Based Microspheres, Liquid Embolics, Onyx (LES and HD-500), TRUFILL nBCA LES, and Nanoparticles and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/novel-drug-delivery-systems-cancer-therapy-market/ The global novel drug delivery systems for cancer therapy market segmentation is based on technology types such as embolization particles, drug eluting beads, PVA particles, microspheres, gelatin-based, selective internal radiation therapy (SIRT), TheraSphere, SIR-Spheres, Holmium-based Microspheres, Liquid Embolics, Onyx (LES and HD-500), TRUFILL nBCA LES, and nanoparticles. The global novel drug delivery systems for cancer therapy market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global novel drug delivery systems for cancer therapy market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global novel drug delivery systems for cancer therapy market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. Major players operating in the global novel drug delivery systems for cancer therapy market and included in this report are Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc. and Terumo Medical Corporation. 1. Technology 1.1.1. Drug Eluting Beads 1.1.2. PVA particles, microspheres, gelatin-based 1.1.3. Selective Internal Radiation Therapy (SIRT) 1.1.4. TheraSphere 1.1.5. SIR-Spheres 1.1.6. Holmium-based Microspheres 1.1.7. Liquid Embolics 1.1.7.1. Onyx (LES and HD-500) 1.1.7.2. TRUFILL nBCA LES 1.1.8. Nanoparticles 2. Geography (Region, Country) 2.1. North America (U.S., Canada) 2.2. Latin America (Brazil, Mexico, Rest of LA) 2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 2.4. Asia Pacific (Japan, China, India, Rest of APAC) 2.5. Rest of the World 3. Company Profiles 3.1. Advanced Medical Isotope Corporation 3.2. Bind Therapeutics 3.3. Boston Scientific Corporation 3.4. BTG plc 3.5. CeloNova BioSciences, Inc. 3.6. Cook Medical, Inc. 3.7. Cospheric LLC 3.8. Covidien, plc 3.9. Eckert & Ziegler BEBIG 3.10. EmboMedics, Inc. 3.11. Kobo Products, Inc. 3.12. Merit Medical Systems, Inc. 3.13. Mo-Sci Corporation 3.14. Nanobiotix 3.15. Polysciences, Inc. 3.16. Sirtex Medical, Inc. 3.17. Terumo Medical Corporation To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/novel-drug-delivery-systems-cancer-therapy-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, May 09, 2017 --( PR.com )-- Novel drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. The novel drug delivery systems minimize drug degradation and loss, prevent harmful side-effects and increase drug bioavailability and the fraction of the drug accumulated in the required zone. A large variety of embolic agents are used by interventional radiologists for the selective occlusion of arteries supplying blood to tumors which depends on various factors including size of the vessel to be embolized, duration of the vessel to be occluded, desired clinical outcome and also the intrinsic properties and behavior of the agent.Browse Novel Drug Delivery Systems for Cancer Therapy Market by Technology Types - Embolization Particles, Drug Eluting Beads, PVA Particles, Microspheres, Gelatin-Based, Selective Internal Radiation Therapy (SIRT), Therasphere, SIR-Spheres, Holmium-Based Microspheres, Liquid Embolics, Onyx (LES and HD-500), TRUFILL nBCA LES, and Nanoparticles and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/novel-drug-delivery-systems-cancer-therapy-market/The global novel drug delivery systems for cancer therapy market segmentation is based on technology types such as embolization particles, drug eluting beads, PVA particles, microspheres, gelatin-based, selective internal radiation therapy (SIRT), TheraSphere, SIR-Spheres, Holmium-based Microspheres, Liquid Embolics, Onyx (LES and HD-500), TRUFILL nBCA LES, and nanoparticles.The global novel drug delivery systems for cancer therapy market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global novel drug delivery systems for cancer therapy market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global novel drug delivery systems for cancer therapy market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.Major players operating in the global novel drug delivery systems for cancer therapy market and included in this report are Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc, Eckert & Ziegler BEBIG, EmboMedics, Inc., Kobo Products, Inc., Merit Medical Systems, Inc., Mo-Sci Corporation, Nanobiotix, Polysciences, Inc., Sirtex Medical, Inc. and Terumo Medical Corporation.1. Technology1.1.1. Drug Eluting Beads1.1.2. PVA particles, microspheres, gelatin-based1.1.3. Selective Internal Radiation Therapy (SIRT)1.1.4. TheraSphere1.1.5. SIR-Spheres1.1.6. Holmium-based Microspheres1.1.7. Liquid Embolics1.1.7.1. Onyx (LES and HD-500)1.1.7.2. TRUFILL nBCA LES1.1.8. Nanoparticles2. Geography (Region, Country)2.1. North America (U.S., Canada)2.2. Latin America (Brazil, Mexico, Rest of LA)2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)2.4. Asia Pacific (Japan, China, India, Rest of APAC)2.5. Rest of the World3. Company Profiles3.1. Advanced Medical Isotope Corporation3.2. Bind Therapeutics3.3. Boston Scientific Corporation3.4. BTG plc3.5. CeloNova BioSciences, Inc.3.6. Cook Medical, Inc.3.7. Cospheric LLC3.8. Covidien, plc3.9. Eckert & Ziegler BEBIG3.10. EmboMedics, Inc.3.11. Kobo Products, Inc.3.12. Merit Medical Systems, Inc.3.13. Mo-Sci Corporation3.14. Nanobiotix3.15. Polysciences, Inc.3.16. Sirtex Medical, Inc.3.17. Terumo Medical CorporationTo request Table of Contents and Sample Pages of this report visit:https://www.ihealthcareanalyst.com/report/novel-drug-delivery-systems-cancer-therapy-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com


Wiseguyreports.Com Adds “Cosmetic Pigments -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database This report studies sales (consumption) of Cosmetic Pigments in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Cosmetic Pigments in these regions, from 2011 to 2021 (forecast), like United States China Europe Japan Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Cosmetic Pigments in each application, can be divided into Application 1 Application 2 Application 3 Global Cosmetic Pigments Sales Market Report 2016 1 Cosmetic Pigments Overview 1.1 Product Overview and Scope of Cosmetic Pigments 1.2 Classification of Cosmetic Pigments 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Application of Cosmetic Pigments 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 1.4 Cosmetic Pigments Market by Regions 1.4.1 United States Status and Prospect (2011-2021) 1.4.2 China Status and Prospect (2011-2021) 1.4.3 Europe Status and Prospect (2011-2021) 1.4.4 Japan Status and Prospect (2011-2021) 1.5 Global Market Size (Value and Volume) of Cosmetic Pigments (2011-2021) 1.5.1 Global Cosmetic Pigments Sales and Growth Rate (2011-2021) 1.5.2 Global Cosmetic Pigments Revenue and Growth Rate (2011-2021) 7 Global Cosmetic Pigments Manufacturers Analysis 7.1 Sun Chemicals 7.1.1 Company Basic Information, Manufacturing Base and Competitors 7.1.2 Cosmetic Pigments Product Type, Application and Specification 7.1.2.1 Type I 7.1.2.2 Type II 7.1.3 Sun Chemicals Cosmetic Pigments Sales, Revenue, Price and Gross Margin (2011-2016) 7.1.4 Main Business/Business Overview 7.2 Sensient Cosmetic Technologies 7.2.1 Company Basic Information, Manufacturing Base and Competitors 7.2.2 100 Product Type, Application and Specification 7.2.2.1 Type I 7.2.2.2 Type II 7.2.3 Sensient Cosmetic Technologies Cosmetic Pigments Sales, Revenue, Price and Gross Margin (2011-2016) 7.2.4 Main Business/Business Overview 7.3 Sudarshan Chemical Industries 7.3.1 Company Basic Information, Manufacturing Base and Competitors 7.3.2 123 Product Type, Application and Specification 7.3.2.1 Type I 7.3.2.2 Type II 7.3.3 Sudarshan Chemical Industries Cosmetic Pigments Sales, Revenue, Price and Gross Margin (2011-2016) 7.3.4 Main Business/Business Overview 7.4 EMP Performance Materials 7.4.1 Company Basic Information, Manufacturing Base and Competitors 7.4.2 Nov Product Type, Application and Specification 7.4.2.1 Type I 7.4.2.2 Type II 7.4.3 EMP Performance Materials Cosmetic Pigments Sales, Revenue, Price and Gross Margin (2011-2016) 7.4.4 Main Business/Business Overview 7.5 Kobo Products Inc. 7.5.1 Company Basic Information, Manufacturing Base and Competitors 7.5.2 Product Type, Application and Specification 7.5.2.1 Type I 7.5.2.2 Type II 7.5.3 Kobo Products Inc. Cosmetic Pigments Sales, Revenue, Price and Gross Margin (2011-2016) 7.5.4 Main Business/Business Overview 7.6 Geotech International B.V. 7.6.1 Company Basic Information, Manufacturing Base and Competitors 7.6.2 Million USD Product Type, Application and Specification 7.6.2.1 Type I 7.6.2.2 Type II 7.6.3 Geotech International B.V. Cosmetic Pigments Sales, Revenue, Price and Gross Margin (2011-2016) 7.6.4 Main Business/Business Overview 7.7 Huntsman (Rockwood Pigments) 7.7.1 Company Basic Information, Manufacturing Base and Competitors 7.7.2 Chemical & Material Product Type, Application and Specification 7.7.2.1 Type I 7.7.2.2 Type II 7.7.3 Huntsman (Rockwood Pigments) Cosmetic Pigments Sales, Revenue, Price and Gross Margin (2011-2016) 7.7.4 Main Business/Business Overview 7.8 Lanxess AG 7.8.1 Company Basic Information, Manufacturing Base and Competitors 7.8.2 Product Type, Application and Specification 7.8.2.1 Type I 7.8.2.2 Type II 7.8.3 Lanxess AG Cosmetic Pigments Sales, Revenue, Price and Gross Margin (2011-2016) 7.8.4 Main Business/Business Overview 7.9 Clariant 7.9.1 Company Basic Information, Manufacturing Base and Competitors 7.9.2 Product Type, Application and Specification 7.9.2.1 Type I 7.9.2.2 Type II 7.9.3 Clariant Cosmetic Pigments Sales, Revenue, Price and Gross Margin (2011-2016) 7.9.4 Main Business/Business Overview 7.10 BASF SE 7.10.1 Company Basic Information, Manufacturing Base and Competitors 7.10.2 Product Type, Application and Specification 7.10.2.1 Type I 7.10.2.2 Type II 7.10.3 BASF SE Cosmetic Pigments Sales, Revenue, Price and Gross Margin (2011-2016) 7.10.4 Main Business/Business Overview


Patent
Kobo Products Inc. | Date: 2015-12-31

This disclosure provides sunscreen products that contain metal oxide powders having discrete size distributions. Metal oxide powders include, for example, zinc oxide and titanium dioxide. Sunscreen products made in accordance with the principles of this disclosure contain metal oxide powders having primary particle sizes of about 10-30 nm and about 50-200 nm.


The present invention provides compositions for natural cosmetic products and, more particularly, to natural ester, wax or oil treated pigments, the products of such treated pigments and cosmetic products incorporating pigments treated with natural ingredients.


A wax-resin composite is made by melting thermoplastic hydrocarbon resin, optionally with an antioxidant. The melted thermoplastic hydrocarbon resin and waxes are blended at a temperature sufficient to melt the waxes. After blending and melting, the blended thermoplastic hydrocarbon resin and waxes are allowed to solidify. Solidification is followed by post-processing the wax-resin composite mixture to form slabs, pastilles, flakes or other forms. A method for producing a wax-resin composite comprises at least partially solvating a thermoplastic resin in a solvent to form a resin-solvent blend. This may be done at a heat of 80-85 C. A composition of molten wax is blended with the resin-solvent blend. The resin-solvent blend and a molten wax are blended to form a wax-resin blend. This is followed by removing the solvent from said wax-resin blend.


This application discloses an aqueous dispersion of waxes, polymers, pigments and other functional additives, which can be used as a concentrate of an eye make-up composition. The dispersion contains about 70% solids and can be diluted at room temperature and adjusted with additional ingredients if desired, which enables commercial cosmetic manufacturers to develop and manufacture new formulations with the minimal effort and cost.


A macroparticle sunscreen powder and methods of making the same. The macroparticle sunscreen powder includes a plurality of macroparticle particles that include UV attenuating particles in a matrix material selected from the group consisting of a natural latex, polyacrylate, polymethacrylate, polyurethane, polyvinyl acetate, styrene-butadiene rubber, acrylonitrile butadiene styrene copolymer, and combinations thereof.


Disclosed is a composition having a substrate comprising metal oxide particles. The substrate has a coating thereon that includes an organic dispersant present in a amount that renders the substrate self-dispersible. Also disclosed is a composition, such as a cosmetic composition, that includes that self-dispersible coated substrate, and a process that includes coating a particulate metal oxide with an organic dispersant to render the metal oxide self dispersible.


Disclosed is a composition having a substrate comprising metal oxide particles. The substrate has a coating thereon that includes an organic dispersant present in a amount that renders the substrate self-dispersible. Also disclosed is a composition, such as a cosmetic composition, that includes that self-dispersible coated substrate, and a process that includes coating a particulate metal oxide with an organic dispersant to render the metal oxide self-dispersible.


The present invention provides UV attenuating nanoparticles entrapped in porous particulates that are coated with a wax material. The porous particulates also include a fatty acid applied to the wax coating. Also provided is a method of producing a powder comprised of UV attenuating nanoparticles entrapped in porous particulates coated with a wax material. Further provided is a composition, such as a cosmetic composition, which includes the porous particulates loaded with the UV attenuating nanoparticles.

Loading Kobo Products Inc. collaborators
Loading Kobo Products Inc. collaborators